Episode Details
Back to Episodes
Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer
Published 2 years, 1 month ago
Description
Matt Galsky describes his ESMO 2024 abstract of disitimab vedotiin + pembrlizumab in bladder cancer